CompletedNCT00443144

D3-GHR Polymorphism and Turner Syndrome

Studying Turner syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital Tuebingen
Principal Investigator
Gerhard Binder, M.D. PhD
University-Children's Hospital Tübingen
Intervention
recombinant human growth hormone(drug)
Eligibility
14 years · FEMALE
Timeline
20052007

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00443144 on ClinicalTrials.gov

Other trials for Turner syndrome

Additional recruiting or active studies for the same condition.

See all trials for Turner syndrome

← Back to all trials